EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS091-21445 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr17:78227310-78229650 
Target genes
TF binding sites/motifs
Number: 28             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:78228046-78228064CTTTCCTTCCTTCCTTCC-10.53
EWSR1-FLI1MA0149.1chr17:78228068-78228086CTTTCCTTCCTTCCTTCC-10.53
EWSR1-FLI1MA0149.1chr17:78228089-78228107CTTTCCTTCCTTCCTTCC-10.53
EWSR1-FLI1MA0149.1chr17:78228114-78228132CCTTGCTCCCTTCCTTTT-6.09
EWSR1-FLI1MA0149.1chr17:78228106-78228124CTTTCCTCCCTTGCTCCC-6.27
EWSR1-FLI1MA0149.1chr17:78228147-78228165TTTTCTTTCCTTTCTTCC-6.4
EWSR1-FLI1MA0149.1chr17:78228042-78228060CTTCCTTTCCTTCCTTCC-6.98
EWSR1-FLI1MA0149.1chr17:78228064-78228082CTTCCTTTCCTTCCTTCC-6.98
EWSR1-FLI1MA0149.1chr17:78228127-78228145CTTTTCTTTCTTCCTTCC-6.98
EWSR1-FLI1MA0149.1chr17:78228110-78228128CCTCCCTTGCTCCCTTCC-7.04
EWSR1-FLI1MA0149.1chr17:78228037-78228055CCTTCCTTCCTTTCCTTC-7.26
EWSR1-FLI1MA0149.1chr17:78228033-78228051TTTTCCTTCCTTCCTTTC-7.66
EWSR1-FLI1MA0149.1chr17:78228050-78228068CCTTCCTTCCTTCCCTTC-8.32
EWSR1-FLI1MA0149.1chr17:78228097-78228115CCTTCCTTCCTTTCCTCC-8.34
EWSR1-FLI1MA0149.1chr17:78228085-78228103CTTTCTTTCCTTCCTTCC-8.46
EWSR1-FLI1MA0149.1chr17:78228076-78228094CCTTCCTTCCTTTCTTTC-8.57
EWSR1-FLI1MA0149.1chr17:78228151-78228169CTTTCCTTTCTTCCTTCC-8.5
EWSR1-FLI1MA0149.1chr17:78228155-78228173CCTTTCTTCCTTCCTTTC-8
EWSR1-FLI1MA0149.1chr17:78228072-78228090CCTTCCTTCCTTCCTTTC-9.6
EWSR1-FLI1MA0149.1chr17:78228093-78228111CCTTCCTTCCTTCCTTTC-9.6
NFE2L1MA0089.2chr17:78228742-78228757CTGTGACTCAGCAGT+6.6
ZNF263MA0528.1chr17:78228085-78228106CTTTCTTTCCTTCCTTCCTTC-6.03
ZNF263MA0528.1chr17:78228038-78228059CTTCCTTCCTTTCCTTCCTTC-6.23
ZNF263MA0528.1chr17:78228192-78228213CCCTTTCTTCCTCCCTCCACC-6.35
ZNF263MA0528.1chr17:78228147-78228168TTTTCTTTCCTTTCTTCCTTC-6.3
ZNF263MA0528.1chr17:78228060-78228081TTCCCTTCCTTTCCTTCCTTC-6.59
ZNF263MA0528.1chr17:78228097-78228118CCTTCCTTCCTTTCCTCCCTT-6.65
ZNF263MA0528.1chr17:78228188-78228209TTCTCCCTTTCTTCCTCCCTC-7.3
Number of super-enhancer constituents: 14             
IDCoordinateTissue/cell
SE_01497chr17:78227322-78229959Adrenal_Gland
SE_15364chr17:78225690-78234366CD4_Memory_Primary_7pool
SE_18860chr17:78226037-78230019CD4p_CD25-_Il17-_PMAstim_Th
SE_19614chr17:78225953-78230164CD4p_CD25-_Il17p_PMAstim_Th17
SE_40468chr17:78227023-78232198K562
SE_43375chr17:78227256-78229359Lung
SE_47414chr17:78225595-78234384Panc1
SE_50802chr17:78227600-78229589Sigmoid_Colon
SE_53776chr17:78227408-78230038Spleen
SE_55643chr17:78228158-78228680Thymus
SE_55643chr17:78228734-78229116Thymus
SE_59307chr17:78226350-78240148Ly3
SE_61907chr17:78225911-78238929Toledo
SE_65788chr17:78225595-78230256Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr177822820778228993
chr177822847678228940
Enhancer Sequence
TCTGCGTGGT ATTTTGGTCT ATATATGCAT CATAATTGAC TTACCGAGCC CTCTGTTCAA 60
CGTGTGCGTG GGTTAGAGAC GGGATCGTGC CTCCTTTAGA TGTGTCAGTT GAAGCCCTTG 120
CCCTCTATGT GACTGCGTTT GGAAACAGGG CTTTTAGGGG GTAACTAGGT TTAATGAAGG 180
TCATAAAGGT GGGCCCTGAA CCGATAGCTT TAGTGTCCTC GTGAGAAGAG ACGCCAGAGA 240
GCTCGTTCTC TGCACCCTCA CACCCCAGGG AACTCCATGA GAGGACACGG CAAAACCAGG 300
CCATGCGCCC ACCAGGAAGA AAGGCCTCAT GAGGACCCCA GCCTCCAAAA CTGGGAGAAG 360
ATGAATCTCT GTGCTAGGCC CCGCAGCCTG GGGTGATCTG TGACGGCGGC CTGAGCAGGT 420
GAGGACTGCC TGCATGTTTG TATTTTTATG AATGCTTTGA TTGAGTCTGG GGGTAAATCC 480
CTGGAGGCCT GTGGCAGCCT CAGAGGTGTG TTCTCCCTGC ACTTTCTTCA AGAAGAATGT 540
GGCCTGCCCT ACTGAGCCTC GTTCTGCCCG TTCTGCCCGG GCAGTCCCGG CCAATGTCAG 600
CGCAGCAAGG GGAGGGCCTC TGTAACCAGG GCTGCTGGCT GCGGGGCTCC CCACTGGACA 660
CGGGAGTGGA CATTGGAGTG TCCTTCATCC GCGTCACTCT TCCAGGTCCC TTGCCTCCTC 720
CCATTTTCCT TCCTTCCTTT CCTTCCTTCC TTCCCTTCCT TTCCTTCCTT CCTTCCTTTC 780
TTTCCTTCCT TCCTTCCTTT CCTCCCTTGC TCCCTTCCTT TTCTTTCTTC CTTCCGTTTT 840
TCTTTCCTTT CTTCCTTCCT TTCATTTTTT TCTTCCCGTT CTCCCTTTCT TCCTCCCTCC 900
ACCCCTTTCT TCTCACTGTG TTCCCCAGGC TGGTCTTCAA CTCCTGGGCT CAAGCAATCC 960
TCTTGCCTCA GCCTCTGGTG TGGCTGGGAC CACAGACACA TGCCACCGCG CCAGGCTAAT 1020
TTGTTAATTG TTTTTATAGA GACAGGGTCT CACTTTGTTT CCCAGGCTCG TCTCAAACTC 1080
CTGGGCTCAA GTGATACTCC AGCTTCAGCC TGAAGTGCTG GAATTAAGGT GTGAGCCACC 1140
ATGCCTGGCC CTCTCTCATT CACAAGTGAA CCATTCACCC CTGCCCTCCA ATCCATGTCG 1200
TTTCTGACCT CAGGCAGCTT CTCTTTCTAC ATAAAGTGAA CCTGTCCCAA AGCTGTGCTC 1260
ACTGGGCCCC CCTGCCAGGG CTGGAAGAGG CAGCAGTTCA CATTTGGCTT GCACTCACAT 1320
ACCAAGGGCA TCCATGCTTG AACCTAGACA TGGTTCATTC ACAGGGATGG GTGAAGGTAA 1380
ACAGACTGTG GCGGGCACTA GGCACTATCA GTTTCATAAA TCTGCATACC ACCTGTGACT 1440
CAGCAGTTAT GCTTCTCGGA ATCTACTCAA ACATGCTTGA GTCAGCCTTC CAGGAAGCAG 1500
GCACAAGGAC GTTTGTGACA ACTTGGTCAG TAATTTTAAG AAGTAGGAAG AAACCTGAGT 1560
TTCTCTGAAT TCGGTAACAT CTTGACTGTA GGACACACGA ATAATGCCGT GGAATATTGT 1620
GCAGCAGTTA AAAGAAATGA GGTGAAGGCC GGGTGTGGCA GCTCACGCCT GTTATCTCAG 1680
CACTTTGGGA GGCCGAGGCT GGTGGATCAC TTAAGGTCAG GAGTTTGAGA CCAGTCTGGC 1740
CAACATGGCG AAACCCTGTC TCTACTAAAA ATACAAAAAT TAGCTGACCT CTGTGACAGA 1800
GTGAGACTCT GCCTCAAAAA AAAAAAAAAA AAAAAAAAAG AGAAATGAGG TGAAGCTTTA 1860
AGTTGTAACA CTGATTTTGG GGTGCAATAA AGCAAGTTGC AGAATGATAC CCATGTTAAG 1920
ATGCTATTTG AGTGAACACA CGGACCAAAC AATTCTATGT TGGGTACAAA TTTAAGAAAG 1980
AGTTCTGGGC TGGGCACGGT GGCTCACAAC TGTAATCCCA GCACTCTGGG AGGGTGAGTC 2040
GGATGGATCA GGAGGTCAGG ACTTCTAGAC TAGCCTGGCC AATATGGTGA AACCCCATCT 2100
CTACTAAAAA TACAAAAATT AGCCAGGCGT GTTGGCGCGT GTCTGGAGTC CCAGCTACTC 2160
AGGAGACTAA GGTAGGAGAA TCACTTGAAC CCGGGAGGCA GAGGTTGCAG TGAGCTGAGA 2220
TCATGCCACT GCACTCTGGC CTGGGCAACA GAGCGAGACT CAAAAAATAA ATAAATAAAT 2280
AAATAAAATA AATAAGAGTT TTCTGCACTT TGGGAGGCCT GTAGTCCCAG CTACTCTGGA 2340